Selective JAK1 and JAK2 inhibition by baricitinib also stabilized actin cytoskeletal structures and restored the expression of elemental proteins in podocytes, ultimately exerting its efficacy on proteinuria caused by LN. This evidence concerns the gene JAK1 and lobular neoplasia.